<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/gsk-b7h3-adc-first-survival-win</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:29:10.427Z</news:publication_date>
      <news:title>GSK Just Won the First Survival Battle in Oncology&apos;s Hottest New Target Race</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/novartis-entresto-decline-q2-2026-earnings-beat</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:28:11.263Z</news:publication_date>
      <news:title>Novartis Just Lost Half Its Best-Seller. Wall Street Shrugged.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/dyne-duchenne-drug-fda-fast-lane</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:27:18.821Z</news:publication_date>
      <news:title>Dyne&apos;s Duchenne Drug Just Got the FDA&apos;s Fast Lane</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:26:27.705Z</news:publication_date>
      <news:title>The Eye Disease Nobody Could Treat Just Met Its Match</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/glp1-giants-novo-nordisk-sues-eli-lilly-false-advertising</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:25:32.814Z</news:publication_date>
      <news:title>The GLP-1 Giants Are Suing Each Other Now</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/tempus-ai-personalis-acquisition-oncology-data</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:24:41.058Z</news:publication_date>
      <news:title>Tempus AI Just Bet $1.5 Billion That It Can Own Cancer&apos;s Data Layer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/biotech-cmo-fugitive-fake-identity</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:23:47.597Z</news:publication_date>
      <news:title>The Biotech CMO Who Didn&apos;t Exist</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/abbott-cyberattack-q2-earnings-july-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:22:56.208Z</news:publication_date>
      <news:title>Abbott&apos;s Hackers Claim 30 Million Records. Abbott Says Everything&apos;s Fine.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/two-minutes-wegovy-telehealth-safety</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:22:00.089Z</news:publication_date>
      <news:title>Two Minutes to Decide If You Need Wegovy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/ozempic-generic-semaglutide-canada-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:21:10.417Z</news:publication_date>
      <news:title>Ozempic Just Lost Its Monopoly in a G7 Country</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/samsung-biologics-polypeptide-acquisition-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-21T14:20:19.619Z</news:publication_date>
      <news:title>Samsung Biologics Just Made a $1.8 Billion Bet on Your Ozempic Supply Chain</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pentagon-flu-vaccine-mandate-reversal-texas-outbreak</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:30:29.198Z</news:publication_date>
      <news:title>The Pentagon Dropped Its Flu Shot Rule. Weeks Later, 300 Troops Got Sick.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/scribe-therapeutics-ipo-crispr-cholesterol</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:29:39.782Z</news:publication_date>
      <news:title>One Shot to Kill Your Cholesterol Forever? This Startup Is Betting $75 Million on It.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/mwyngil-therapeutics-obesity-beyond-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:28:46.064Z</news:publication_date>
      <news:title>This Obesity Startup Thinks GLP-1s Are Yesterday&apos;s News</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/bms-nvidia-vera-rubin-ai-supercomputer-drug-discovery</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:27:52.036Z</news:publication_date>
      <news:title>Big Pharma&apos;s New Drug Discovery Weapon Costs More Than Most Startups</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/china-insurance-glp1-pfizer-innovent</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:26:57.092Z</news:publication_date>
      <news:title>China&apos;s Insurance List Just Cracked Open for Two GLP-1 Newcomers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/india-first-dengue-vaccine-qdenga-approved</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:26:09.132Z</news:publication_date>
      <news:title>India Just Got Its First Dengue Vaccine. It Only Took Forever.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/ollin-biosciences-330m-ophthalmology-bet</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:25:10.438Z</news:publication_date>
      <news:title>The $330M Bet That Eyes Are the Next Big Thing in Biotech</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/senator-investigation-fda-rare-disease-rejections</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:24:20.572Z</news:publication_date>
      <news:title>The Senator Who Thinks the FDA Is Killing Rare Disease Patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-liked-the-drug-hated-the-factory-lantheus</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:23:30.464Z</news:publication_date>
      <news:title>The FDA Liked the Drug. It Hated the Factory.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/new-drug-launch-prices-dropped-2025</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:22:43.186Z</news:publication_date>
      <news:title>New Drug Prices Just Dropped for the First Time in Years. Don&apos;t Celebrate Yet.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sonothera-ultrasound-gene-therapy-duchenne</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T14:21:52.275Z</news:publication_date>
      <news:title>The Gene Therapy That Sounds Too Good to Be True (Because It Uses Sound)</news:title>
    </news:news>
  </url>
</urlset>